Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
BlackRock, Inc. reported a passive ownership position in First Tracks Biotherapeutics Inc. common stock. BlackRock beneficially owns 1,919,376 shares, representing 5.5% of the class. It has sole voting power over 1,886,631 shares and sole dispositive power over all 1,919,376 shares, with no shared voting or dispositive power. Various underlying clients have rights to dividends or sale proceeds, but no single client holds more than five percent of First Tracks Biotherapeutics’ outstanding common shares.
Key Figures
Beneficial ownership:1,919,376 sharesPercent of class owned:5.5 %Sole voting power:1,886,631 shares+3 more
6 metrics
Beneficial ownership1,919,376 sharesCommon stock of First Tracks Biotherapeutics beneficially owned by BlackRock
Percent of class owned5.5 %Portion of First Tracks Biotherapeutics common stock class held by BlackRock
Sole voting power1,886,631 sharesShares for which BlackRock may vote or direct the vote
Shared voting power0Shares for which voting power is shared by BlackRock
Sole dispositive power1,919,376 sharesShares for which BlackRock may dispose or direct disposition
Shared dispositive power0Shares with shared dispositive power
Key Terms
beneficially owned, sole voting power, sole dispositive power, percent of class, +1 more
5 terms
beneficially ownedfinancial
"this reflects the securities beneficially owned, or deemed to be beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting powerfinancial
"Sole Voting Power 1,886,631.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive powerfinancial
"Sole Dispositive Power 1,919,376.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
percent of classfinancial
"Percent of class: 5.5 %"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
parent holding companyfinancial
"If a parent holding company has filed this schedule"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of FIRST TRACKS BIOTHERAPEUTICS INC (TRAX) does BlackRock currently own?
BlackRock reports beneficial ownership of 5.5% of First Tracks Biotherapeutics’ common stock, representing institutional holdings managed by certain BlackRock business units and their subsidiaries and affiliates.
How many TRAX shares are beneficially owned by BlackRock, Inc.?
BlackRock beneficially owns 1,919,376 shares of First Tracks Biotherapeutics common stock, as disclosed in the Schedule 13G ownership statement filed by the firm.
What voting power does BlackRock have over its TRAX holdings?
BlackRock has sole voting power over 1,886,631 shares of First Tracks Biotherapeutics and no shared voting power, indicating decisions are controlled by the reporting BlackRock business units.
What dispositive power does BlackRock hold in First Tracks Biotherapeutics (TRAX)?
BlackRock has sole dispositive power over 1,919,376 shares of First Tracks Biotherapeutics and no shared dispositive power, meaning it alone directs how these shares may be sold or otherwise disposed of.
Do any individual BlackRock clients hold more than 5% of TRAX shares?
No. While various persons have rights to dividends or sale proceeds on the TRAX shares managed by BlackRock, no one person’s interest exceeds five percent of First Tracks Biotherapeutics’ outstanding common stock.
Who signed the Schedule 13G for BlackRock’s TRAX position and in what capacity?
The Schedule 13G was signed by Spencer Fleming, who is identified as a Managing Director of BlackRock, acting under a Power of Attorney (Exhibit 24).
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
FIRST TRACKS BIOTHERAPEUTICS INC
(Name of Issuer)
Common Stock
(Title of Class of Securities)
337185102
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
337185102
1
Names of Reporting Persons
BlackRock, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
1,886,631.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
1,919,376.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,919,376.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.5 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
FIRST TRACKS BIOTHERAPEUTICS INC
(b)
Address of issuer's principal executive offices:
10770 Wateridge Circle, Suite 210 San Diego CA 92121
Item 2.
(a)
Name of person filing:
BlackRock, Inc.
In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)
Address or principal business office or, if none, residence:
BlackRock, Inc., 50 Hudson Yards New York, NY 10001
(c)
Citizenship:
See Item 4 of Cover Page
(d)
Title of class of securities:
Common Stock
(e)
CUSIP Number(s):
337185102
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
1919376
(b)
Percent of class:
5.5 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
1886631
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
1919376
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of FIRST TRACKS BIOTHERAPEUTICS INC. No one person's interest in the common stock of FIRST TRACKS BIOTHERAPEUTICS INC is more than five percent of the total outstanding common shares.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Exhibit 99
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
